{"prompt": "['Appendix 44', 'Clinical Criteria for Diagnosing Anaphylaxis', 'These criteria are taken from a summary report from the second symposium on the definition', 'and management of anaphylaxis, conducted by the National Institute of Allergy and', 'Infectious Disease/Food Allergy and Anaphylaxis Network.\u00b9 Anaphylaxis is highly likely when', 'any one of the following three criteria is fulfilled:', '1. Acute onset of an illness (minutes to several hours) with involvement of the skin,', 'mucosal tissue, or both (e.g., generalized hives, pruritus or flushing, swollen lips,', 'tongue/uvula)', 'AND AT LEAST ONE OF THE FOLLOWING:', 'Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced', 'peak expiratory flow, hypoxemia)', 'Reduced blood pressure or associated symptoms of end-organ dysfunction (e.g.,', 'hypotonia, syncope, incontinence).', '2. Two or more of the following that occur rapidly after exposure to a likely allergen for that', 'patient (minutes to several hours):', 'Involvement of the skin-mucosal tissue (e.g., generalized hives, itch-flush, swollen', 'lips-tongue-uvula)', 'Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, reduced', 'peak expiratory flow, hypoxemia)', 'Reduced blood pressure or associated symptoms (e.g., hypotonia, syncope,', 'incontinence)', 'Persistent gastrointestinal symptoms (e.g., crampy abdominal pain, vomiting).', '3. Reduced blood pressure after exposure to known allergen for that patient (minutes to', 'several hours):', 'Infants and children: low systolic blood pressure (age specific) or greater than 30%', 'decrease in systolic blood pressure [a]', 'Adults: systolic blood pressure of less than 90 mmHg or greater than 30% decrease from', \"that person's baseline.\", '1 Sampson HA, Mu\u00f1oz-Furlong A, Campbell RL, et al. Second symposium on the definition and', 'management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious', 'Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-7.', 'a. Low systolic blood pressure for children is defined as less than 70 mmHg from 1 month to 1 year,', 'less than (70 mmHg + [2 X age]) from 1 to 10 years, and less than 90 mmHg from 11 to 17 years.', 'Emicizumab - F. Hoffmann-La Roche Ltd', '168 / Protocol MO39129, Version 3']['Appendix 55', 'WHO Toxicity Grading Scale for Determining the Severity of Laboratory Abnormalities and Adverse', 'Events', 'Item', 'Grade 1 Toxicity', 'Grade 2 Toxicity', 'Grade 3 Toxicity', 'Grade 4 Toxicity', 'HEMATOLOGY', 'Hemoglobin', '9.5-10.5 g/dL', '8.0-9.4 g/dL', '6.5-7.9 g/dL', '< 6.5 g/dL', 'Absolute neutrophil count', '1000-1500/mm\u00b3', '750-999/mm\u00b3', '500-749/mm\u00b3', '< 500/mm\u00b3', 'Platelets', '75000-99999/mm\u00b3', '50000-74999/mm\u00b3', '20000-49999/mm\u00b3', '< 20000/mm\u00b3', 'PT', '1.01-1.25 x ULN', '1.26-1.5 x ULN', '1.51-3.0 x ULN', '> 3 x ULN', 'aPTT', '1.01-1.66 x ULN', '1.67-2.33 x ULN', '2.34-3 x ULN', '> 3 x ULN', 'Fibrinogen', '0.75-0.99 x LLN', '0.50-0.74 x LLN', '0.25-0.49 x LLN', '< 0.25 x LLN', 'Fibrin split product', '20-40 g/mL', '1-50 g/mL', '51-60 g/mL', '> 60 g/mL', 'Methemoglobin', '5%-9.9%', '10.0%-14.9%', '15.0%-19.9%', '> 20%', 'LIVER ENZYMES', 'AST (SGOT)', '1.25-2.5 x ULN', '2.6-5 x ULN', '5.1-10 x ULN', '> 10 x ULN', 'ALT (SGPT)', '1.25-2.5 x ULN', '2.6-5 ULN', '5.1-10 x ULN', '> 10 x ULN', 'GGT', '1.25-2.5 x ULN', '2.6-5 ULN', '5.1-10 x ULN', '> 10 x ULN', 'Alkaline phosphatase', '1.25-2.5 x ULN', '2.6-5 ULN', '5.1-10 x ULN', '> 10 x ULN', 'Amylase', '1.1-1.5 x ULN', '1.6-2.0 x ULN', '2.1-5.0 x ULN', '> 5.0 x ULN', 'CHEMISTRIES', '< 116 or mental status', 'Hyponatremia', '130-135 mEq/L', '123-129 mEq/L', '116-122 mEq/L', 'changes or seizures', 'Hypernatremia', '146-150 mEq/L', '151-157 mEq/L', '158-165 mEq/L', '> 165 mEq/L or mental', 'status changes or seizures', 'Emicizumab - F. Hoffmann-La Roche Ltd', '169 / Protocol MO39129, Version 3']\n\n###\n\n", "completion": "END"}